These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1254383)

  • 21. Glycemia and plasma IRI level after tolbutamide in hyposomatrophic dwarfs treated with HGH.
    Soltysik-Wilk E; Rybak M; Golda W
    Ann Med Sect Pol Acad Sci; 1976; (3):113-20. PubMed ID: 973430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Influence of allopurinol on the half-life of tolbutamide and rifamycin-SV in blood of healthy volunteers].
    Gentile S; Porcellini M; Foglia F; Loguercio C; Coltorti M
    Boll Soc Ital Biol Sper; 1979 Feb; 55(4):345-8. PubMed ID: 552849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Responses to intravenous tolbutamide by Nigerians--a preliminary study.
    Adadevoh BK; Bolodeoku JO
    West Afr J Pharmacol Drug Res; 1975 Jun; 2(1):5-9. PubMed ID: 1226732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Studies on the bio-availability of tolbutamide (author's transl)].
    Rupp W; Dibbern HW; Hajdu P; Ross G; Vander Elst E
    Dtsch Med Wochenschr; 1975 Mar; 100(13):690-5. PubMed ID: 1091434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Drug interaction during therapy with tolbutamide. The influence of some commonly used drugs on plasma level and half life in diabetic out-patients (author's transl)].
    Kolenda KD; Grille W; Johnsen K
    Med Klin; 1979 Dec; 74(50):1914-22. PubMed ID: 542176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamics of tolbutamide, glucose, and insulin interrelationships following varying doses of intravenous tolbutamide in normal subjects.
    Ganda OP; Kahn CB; Soeldner JS; Gleason RE
    Diabetes; 1975 Apr; 24(4):354-67. PubMed ID: 1132601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of drug metabolism in man after rifampicin treatment measured by increased hexobarbital and tolbutamide clearance.
    Zilly W; Breimer DD; Richter E
    Eur J Clin Pharmacol; 1975 Dec; 9(2-3):219-27. PubMed ID: 1233266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum insulin and growth hormone response to hemorrhagic shock.
    Cerchio GM; Moss GS; Popovich PA; Butler E; Siegel DC
    Endocrinology; 1971 Jan; 88(1):138-43. PubMed ID: 4991822
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunoreactive glucagon responses to intravenous tolbutamide in chronic pancreatitis.
    Kalk WJ; Vinik AI; Paul M; Leller P; Jackson WP
    Diabetes; 1975 Sep; 24(9):851-5. PubMed ID: 1158044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of food on the bioavailability and pharmacodynamics of tolbutamide in diabetic patients.
    Antal EJ; Gillespie WR; Phillips JP; Albert KS
    Eur J Clin Pharmacol; 1982; 22(5):459-62. PubMed ID: 6749526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid rise of insulin concentration in the plasma after intravenous administration of sodium tobutamide.
    Maingay D; de Ruyter HA; Touber JL; Croughs RJ; Schopman E; Lequin RM
    Lancet; 1967 Feb; 1(7486):361-2. PubMed ID: 4163778
    [No Abstract]   [Full Text] [Related]  

  • 32. Influence of food and age on the single-dose kinetics and effects of tolbutamide and chlorpropamide.
    Sartor G; Melander A; Scherstén B; Wåhlin-Boll E
    Eur J Clin Pharmacol; 1980 Apr; 17(4):285-93. PubMed ID: 6995130
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of different oral anticoagulants on diphenylhydantoin (DPH) and tolbutamide metabolism.
    Skovsted L; Kristensen M; Hansen M; Siersbaek-Nielsen K
    Acta Med Scand; 1976; 199(6):513-5. PubMed ID: 59517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacogenetics of tolbutamide metabolism in humans.
    Scott J; Poffenbarger PL
    Diabetes; 1979 Jan; 28(1):41-51. PubMed ID: 569611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulation of drug metabolism by rifampicin in patients with cirrhosis or cholestasis measured by increased hexobarbital and tolbutamide clearance.
    Zilly W; Breimer DD; Richter E
    Eur J Clin Pharmacol; 1977 Apr; 11(4):287-93. PubMed ID: 862650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Serum insulin values in hypoglycemic shock during suicide attempts with tolbutamide and insuline].
    Creutzfeldt W; Frerichs H; Perings E
    Dtsch Med Wochenschr; 1968 Apr; 93(17):856-60. PubMed ID: 5646124
    [No Abstract]   [Full Text] [Related]  

  • 37. On the question of an interaction between sulindac and tolbutamide in the control of diabetes.
    Ryan JR; Jain AK; McMahon FG; Vargas R
    Clin Pharmacol Ther; 1977 Feb; 21(2):231-3. PubMed ID: 837641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diurnal variation in the effect of tolbutamide.
    Johnson BF; Chura C
    Am J Med Sci; 1974 Aug; 268(2):93-6. PubMed ID: 4472066
    [No Abstract]   [Full Text] [Related]  

  • 39. Interaction between tolbutamide and ketoconazole in healthy subjects.
    Krishnaiah YS; Satyanarayana S; Visweswaram D
    Br J Clin Pharmacol; 1994 Feb; 37(2):205-7. PubMed ID: 8186066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tolbutamide as a stimulator of somatotropin secretion from the hypophysis].
    Spanar E; Uhrín P; Levcík A; Záhradný V
    Z Gesamte Inn Med; 1977 Dec; 32(24):694-5. PubMed ID: 605639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.